Media formats available:
Recommended
- CDMC 2018: Shifting gears in the management of diabetes and CVDBenefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
Prof. Eduard Montanya, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDTranslating mechanisms of GLP-1RAs and SGLT2 inhibitors to CV benefits
Dr. Adie Viljoen, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Screening for Diabetes: When is it meaningful and how should it be performed
Prof. Lars Rydén
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
Prof John E Deanfield